The relationships between SIRT2 and Parkinson’s and Alzheimer’s diseases are becoming clearer, and SIRT2 inhibition is a crucial therapeutic strategy for these diseases. The gene discussed is SIRT2; the disease is early-onset autosomal dominant Alzheimer disease.